Replies to post #94344 on Biotech Values

[DewDiligence]

Are you aware that bullish articles in SeeekingAlpha are contrary indicators more often than not?

[10nisman]

<< CYCC mentioned with Merck and Pfizer: will be monster Monday:
seekingalpha.com/instablog/353981-michael-becker/63734-cyclin-dependent-cancer-confab-preview

At AACR, Cyclacel is introducing a second-generation CDK product candidate, which is currently in investigational new drug [IND]-directed development. The undisclosed molecule is a second generation oral CDK inhibitor with increased potency. Three abstracts related to both seliciclib and the second-generation compound are scheduled for presentation at AACR. >>

jaybird... Thanks for your insightful pump and dump post. Next time hit the YMB's. Thanks.

10nis

[ilpapa]

CYCC had a nice little AACR related run on Friday afternoon - roughly 10%. Was there anything after the bell?

CYCC sometimes seems to be the target of a skilled pump and dump crowd. Since I have a small position I hope to be proven wrong this time.